glp-1 degradation physiology in obesity and development of incretin-based drugs for chronic weight management GLP-1 Receptor Agonists in Periodontology:

Managing Nausea: Proven Strategies That Work Nausea is the side effect people worry about most, and having a solid management plan makes all the difference

Diabetes, Obesity, and Metabolism, 25 (4), 975-984

GLP-1 and Alcohol: What the Evidence Shows Emerging research has sparked interest in whether GLP-1 receptor agonistsmedications primarily used for type 2 diabetes and weight managementmight influence alcohol consumption

Circulation 145 (8), 575585

Demand for those medications has far outpaced supply over the past year, forcing Novo Nordisk and Eli Lilly, the dominant players in the market, to invest heavily to scale up manufacturing